Maximus vs Hims: Compare GLP-1 Programs & Pricing
Side-by-side Maximus and Hims: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Maximus and Hims are two telehealth companies offering prescription GLP-1–based weight management options through virtual clinician visits and partnered pharmacies. This comparison summarizes program structure, pricing transparency, membership requirements, and medical oversight so you can make an informed decision.
Maximus vs Hims: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Maximus | Not listed | $132.99 | Not listed | No |
| Hims | Not listed | Not listed | Not listed | Not listed |
Note: Pricing details may change and some programs display limited public pricing. When a provider does not list a starting price, the company typically requires an intake to provide a quote.
Maximus vs Hims: Medical Process & Accessibility
Maximus generally emphasizes a rapid virtual intake and clinician review to determine eligibility for prescription GLP-1 therapy, while Hims typically includes an intake, clinician consultation, and follow-up touchpoints for dose adjustments. Both rely on licensed U.S. clinicians to evaluate medical history, current medications, and contraindications before prescribing any GLP-1 medication.
Maximus vs Hims: Pricing Comparison
Maximus lists tirzepatide starting at $132.99. Semaglutide starting prices are not listed publicly for Maximus. Hims does not publish clear starting prices for semaglutide or tirzepatide on its standard pricing pages at the time of this comparison. Where a clear public price exists, the lower amount is emphasized for clarity.
Because pricing for compounded or private-label GLP-1 products can vary by dose, shipment frequency, and pharmacy used, we recommend confirming the total cost (medication, shipping, and clinician fees) during the intake process for either provider.
See Maximus Pricing
See Hims Pricing
Maximus vs Hims: Clinical Oversight & Support
Both companies deploy licensed prescribers and medical staff who review your history and assess eligibility for GLP-1 therapy. Clinical oversight typically includes an initial assessment, prescription if appropriate, and instructions for administration and side effect monitoring. Hims is often noted for scheduled follow-ups and dose optimization, while Maximus focuses on a streamlined intake and rapid fulfillment.
Maximus vs Hims: Medication Quality & Safety
These providers commonly coordinate with accredited U.S. pharmacies to fill prescriptions. Compounded GLP-1 formulations are not identical to branded agents (for example, Wegovy® or Mounjaro®) and availability, formulation, and labeling can differ. All prescription decisions should be made by a licensed clinician; patients should report side effects promptly and follow dosing guidance exactly.
Maximus vs Hims: Customer Experience
User feedback often highlights Maximus for affordability and quick onboarding, whereas Hims receives praise for thorough clinician communication and structured follow-up. Shipping times for medication fulfillment commonly range from a few days to about a week after prescription approval, depending on the pharmacy and shipping option.
Read Maximus Reviews
Read Hims Reviews
Maximus vs Hims: Final Verdict
Choose Maximus if you prioritize fast onboarding and a clear published tirzepatide price point. Choose Hims if you want a program that emphasizes follow-up interactions and dose management. Both are telehealth options that connect patients to licensed prescribers; neither should replace in-person care when clinically indicated.
Join Maximus
Get Started with Hims
Disclaimer
This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. GLP-1 medications are prescription drugs with potential side effects; always consult a licensed clinician before beginning any treatment. Availability, pricing, and program details can change and may vary by state and individual medical history.